Underdiagnosis and undertreatment of migraine in Italy: A survey of patients attending for the first time 10 headache centres

Cephalalgia

Volumn 29, Issue 12, 2009, Pages 1285-1293

  Cevoli, S ^a   D'amico, D ^b   Martelletti, P ^c   Valguarnera, F ^d   Del Bene, E ^e   De Simone, R ^f   Sarchielli, P ^g   Narbone, M C ^h   Testa, L ⁱ   Genco, S ^j   Bussone, G ^b   Cortelli, P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c Centro di Riferimento Regionale per le Cefalee   (Italy)

^d Ospedale Padre Antero Micone   (Italy)

^e Dipartimento di Medicina Interna   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF PERUGIA   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^j POLICLINICO   (Italy)

more..

Author keywords

Clinical governance; Healthcare; Migraine diagnosis; Over the counter medications; Triptan

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIEMETIC AGENT; ATENOLOL; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUNARIZINE; GABAPENTIN; IBUPROFEN; NIMESULIDE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PIZOTIFEN; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID;

ADULT; ARTICLE; ASTHENIA; CARDIOVASCULAR SYMPTOM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DRUG UTILIZATION; EMERGENCY WARD; EVALUATION; FEMALE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HEADACHE; HEALTH CARE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; ITALY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MIGRAINE; MIGRAINE ASSESSMENT OF CURRENT THERAPY QUESTIONNAIRE; MIGRAINE SPECIFIC QUALITY OF LIFE QUESTIONNAIRE; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRESCRIPTION; QUALITY OF LIFE; QUESTIONNAIRE; RASH; SCORING SYSTEM; SCREENING; SHORT FORM 12; SIDE EFFECT; WEIGHT GAIN;

ADULT; ANALGESICS; CLINICAL GOVERNANCE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES; HUMANS; ITALY; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROLOGY; NONPRESCRIPTION DRUGS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; VASOCONSTRICTOR AGENTS;

EID: 74549123315     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01874.x     Document Type: Article

References (42)

1. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007 27 : 193 210.
2. D'Alessandro R, Benassi G, Lenzi PL, Gamberini G, Sacquegna T, De Carolis P, Lugaresi E. Epidemiology of headache in the Republic of San Marino. J Neurol Neurosurg Psychiatry 1988 51 : 21 7.
3. Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics 1998 13 : 667 676.
4. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American Migraine Study. Cephalalgia 1996 16 : 231 238.
5. Michel P, Dartigues JF, Lindousli A, Henry P. Loss of productivity and quality of life in migraineurs among French workers: results from the GAZEL cohort. Headache 1997 37 : 71 8.
6. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behavior, and medication use: a Canadian population survey. Can J Neurol Sci 1993 20 : 131 137.
7. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D'Amico D. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 2004 25 (Suppl. 3 S105 7.
8. Steiner TJ. Lifting the burden: the global campaign against headache. Lancet Neurol 2004 3 : 204 205.
9. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999 39 : 190 196.
10. Colas R, Munoz P, Temprano R, Gomez SW, Pascual J. Chronic daily headache with drug analgesic overuse. Epidemiology and impact on quality of life. Neurology 2004 62 : 1338 1342. (Pubitemid 38526046)
11. D'Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache 2005 45 : 553 560.
12. Lipton RB, Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993 43 : 6 10.
13. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: result from the American Migraine Study II. Headache 2001 41 : 638 645.
14. Diamond S, Bigal ME, Silberstein S, Loder E, Michael R, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache 2007 47 : 355 363.
15. Lucas C, Chaffaut C, Artaz MA, Lanteri-Minet M. FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 2005 25 : 267 279.
16. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007 68 : 343 349.
17. Roncolato M, Fabbri L, Recchia G, Cavazzuti L, Visona G, Brignoli O, Medea G. An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPs. Eur Neurol 2000 43 : 102 106.
18. Pavone E, Banfi R, Vaiani M, Panconesi A. Patterns of triptans use: a study based on the records of a community pharmaceutical department. Cephalalgia 2007 27 : 1000 1004.
19. Ferrari A, Pasciullo G, Savino G, Cicero AFG, Ottani A, Bertolini A, Sternieri E. Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study. Cephalalgia 2004 24 : 356 362.
20. Silberstein SD, Rosenberg J. Multispeciality consensus on diagnosis and treatment of headache. Neurology 2000 54 : 1553.
21. Silberstein SD, Winner PK, Chmiel JJ. Migraine preventive medications reduce resource utilization. Headache 2003 43 : 171 178.
22. D'Amico D, Lanteri-Minet M. Migraine preventive therapy: selection of appropriate patients and general principles of management. Expert Rev Neurother 2006 6 : 1147 1157.
23. Lipton RB, Sher AI, Steiner TJ, Bigal ME, Kolodner K, Librman JN, Stewart WF. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003 60 : 441 448.
24. D'Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F et al. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 2006 6 : 691 696.
25. Lofland JF, Johnson NE, Batenhorst A, Nash DB. Changes in resource use and outcomes for patients with migraine treated with sumatriptan. Arch Intern Med 1999 159 : 857 863.
26. Dasbach EJ, Carides GW, Gerth WC, Santanello NC, Pigeon JG, Kramer M. Work and productivity loss in the rizatriptan multiple attack study. Cephalalgia 2000 20 : 830 834.
27. Santanello NC, Polis AB, Hartmaier SL, Kramer MS, Block GA, Silberstein SD. Improvement in migraine-specific quality of life in a clinical trial of rizatriptan. Cephalalgia 1997 17 : 867 872.
28. Colman SS, Brod MI, Krishnamurthy A, Rowland CR, Jirgens KJ, Gomez-Mancilla B. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan. Clin Ther 2001 23 : 127 145.
29. Lainez MJ, Lopez A, Pascual AM. Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study. Headache 2005 45 : 883 890.
30. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 9 160.
31. Dowson AJ, D'Amico D, Tepper SJ, Baos V, Baudet F, Kilminster S. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Neurol Sci 2004 25 : S276 8.
32. Kilminster SG, Dowson AJ, Tepper SJ, Baos V, Baudet F, D'Amico D. Reliability, validity, and clinical utility of the Migraine-ACT questionnaire. Headache 2006 46 : 553 562.
33. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998 51 : 1171 1178.
34. Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong J, Jhingran P. Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1). Headache 2000 40 : 204 215.
35. Gibbs TS, Fleischer AB, Feldman SR, Sam MC, O'Donovan CA. Health care utilization in patients with migraine: demographics and pattern of care in the ambulatory setting. Headache 2003 43 : 330 335.
36. Malik SN, Hopkins M, Young WB, Silberstein SD. Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache 2006 46 : 773 780.
37. Minghetti P, Casiraghi A, Cilurzo F, Montanari L. The situation of OTC drugs in Italy compared to the other EU states. Pharmacol Res 2000 42 : 25 31.
38. Robinson RG. Pain relief for headaches. Is self-medication a problem? Can Fam Physician 1993 39 : 867 868, 871 872.
39. Aguggia M, Cavallini M, Varetto L. Medical-legal issues in headache: penal and civil Italian legislation, working claims, social security, off-label prescription. Neurol Sci 2006 27 : S198 202.
40. Iannacchero R, Cannistrà U, La Vitola A, Peltrone F, De Caro E. Study on management of headache by general practitioners in south Italy. J Headache Pain 2005 6 : 312 314.
41. Beghi E, Allais G, Cortelli P, D'Amico D, De Simone R, d'Onofrio F et al. Headache and anxiety-depressive disorder comorbidity: the HADAS study. Neurol Sci 2007 28 : S217 19.
42. Silberstein SD, Winner PK, Chmiel JJ. Migraine preventive medication reduces resources utilization. Headache 2003 43 : 171 178.